Silva Alison D. 4

What Happened

• Alison D. Silva, President & COO and a director of Jupiter Neurosciences (JUNS), was granted 1,027,304 derivative securities (stock option awards) on 2026-06-02. The Form 4 reports an acquisition at $0.00 (award/grant), i.e., no cash paid by the insider at grant. The filing lists the award as a derivative grant under the Issuer’s 2025 Equity Incentive Plan.

Key Details

• Transaction date: 2026-06-02; Form 4 filed: 2026-06-04 (filed within the standard Form 4 window).
• Reported amount: 1,027,304 options granted; reported acquisition price: $0.00 (award).
• Footnote detail: 427,304 options were a discretionary bonus for fiscal 2025 services and 600,000 options were granted as long‑term incentive compensation under the 2025 Equity Incentive Plan.
• Vesting: options vest over three years beginning September 2, 2026, in equal quarterly installments, subject to continued employment through each vesting date.
• Shares/options owned after transaction: not specified in the provided filing excerpt.
• Exercise price or other economic terms (beyond vesting) are not reported in the summary provided.

Context

• This is a grant of options (compensation), not an open‑market purchase or sale. Grants are common for executive pay and do not by themselves represent buying or selling of shares; value is realized later only if options vest and are exercised (and possibly sold).
• The award’s staged vesting ties future value to continued service and company performance; investors should watch future Form 4s for exercises or sales if/when options vest and are exercised.